Article: Pharma’s Broken Business Model - Part 1

Background

Since early 2020, the lives of the global population have been flipped upside-down and turned inside-out. We were told that these unprecedented & constitution-violating changes were only “temporary” for “emergency” purposes.

If you have been reading this newsletter, it should come as no surprise that there is more that lurks beneath these claims.

As my frustration & analysis of recent events has evolved, I’ve started reconsidering everything we have endured from an economic perspective. We know that there is a debt bubble waiting to pop (if it has not already). There have already been several “mini” debt bubbles which have popped for various industries…all of which were swiftly followed by government bailouts.

Without getting too bogged down in historical detail, keep in mind the following pattern: the closest allies of central bankers (governments & lobbyists) overextend their business practice, and ultimately rely on the population to bail them out.

The pharmaceutical business model has been headed towards collapse for decades. As we will explore from the above work of Kelvin Stott, this was inevitable.

In 2017, Kelvin made the solid argument that in the year 2020, Pharma’s growth would turn negative - i.e. contract. To mitigate this disaster, they would have to act…